Brief: NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK Bispecific Antibody in the American Society of Hematology's Blood Journal

INVO Fertility

11/12/2023 13:10

Dec 11 (Reuters) - INVO Bioscience Inc  INVO.O :
    * NAYA BIOSCIENCES ANNOUNCES PUBLICATION OF NEW DATA FOR ITS
CD38-TARGETED FLEX-NK™ BISPECIFIC ANTIBODY IN THE AMERICAN
SOCIETY OF HEMATOLOGY'S BLOOD JOURNAL
    * NAYA BIOSCIENCES INC.: EXPECTS TO CLOSE PREVIOUSLY
ANNOUNCED
MERGER WITH INVO BIOSCIENCE (NASDAQ: INVO) IN Q1 OF 2024

Source text for Eikon:  ID:nPn8rLWgla 
Further company coverage:  INVO.O 

 ((Reuters.Briefs@thomsonreuters.com;))